Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Net Sales(x) 3.483.302.231.411.20

What is the latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS is 3.48 based on Mar2026 Consolidated results.
Year EV/Net Sales
Mar20263.48
Mar20253.30
Mar20242.23
Mar20231.41
Mar20221.20

How is EV/Net Sales of GLENMARK PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2026 3.48
5.45
Mar2025 3.3
47.98
Mar2024 2.23
58.16
Mar2023 1.41
17.50
Mar2022 1.2 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,659.1 Cr 0.4% -7.5% 11.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.4%

-7.5%

11.7%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses